229 related articles for article (PubMed ID: 33953586)
21. Effect of astragaloside IV against rat myocardial cell apoptosis induced by oxidative stress via mitochondrial ATP-sensitive potassium channels.
Guan FY; Yang SJ; Liu J; Yang SR
Mol Med Rep; 2015 Jul; 12(1):371-6. PubMed ID: 25739067
[TBL] [Abstract][Full Text] [Related]
22. Protective Effects of Tiaoganquzhi Decoction in Treating inflammatory Injury of Nonalcoholic Fatty liver Disease by Promoting CGI-58 and Inhibiting Expression of NLRP3 Inflammasome.
Zhang H; Gao X; Chen P; Wang H
Front Pharmacol; 2022; 13():851267. PubMed ID: 35586044
[TBL] [Abstract][Full Text] [Related]
23. Gypenosides improves nonalcoholic fatty liver disease induced by high-fat diet induced through regulating LPS/TLR4 signaling pathway.
Shen S; Wang K; Zhi Y; Shen W; Huang L
Cell Cycle; 2020 Nov; 19(22):3042-3053. PubMed ID: 33121337
[TBL] [Abstract][Full Text] [Related]
24. Diosgenin attenuates non-alcoholic fatty liver disease in type 2 diabetes through regulating SIRT6-related fatty acid uptake.
Nie K; Gao Y; Chen S; Wang Z; Wang H; Tang Y; Su H; Lu F; Dong H; Fang K
Phytomedicine; 2023 Mar; 111():154661. PubMed ID: 36682299
[TBL] [Abstract][Full Text] [Related]
25. Silencing HIF-1α aggravates non-alcoholic fatty liver disease in vitro through inhibiting PPAR-α/ANGPTL4 singling pathway.
He Y; Yang W; Gan L; Liu S; Ni Q; Bi Y; Han T; Liu Q; Chen H; Hu Y; Long Y; Yang L
Gastroenterol Hepatol; 2021 May; 44(5):355-365. PubMed ID: 33272734
[TBL] [Abstract][Full Text] [Related]
26. Astragaloside IV improves the isoproterenol-induced vascular dysfunction via attenuating eNOS uncoupling-mediated oxidative stress and inhibiting ROS-NF-κB pathways.
Xu C; Tang F; Lu M; Yang J; Han R; Mei M; Hu J; Zhou M; Wang H
Int Immunopharmacol; 2016 Apr; 33():119-27. PubMed ID: 26903414
[TBL] [Abstract][Full Text] [Related]
27. [Role and mechanism of action of fibroblast growth factor-21 in reducing triglyceride in nonalcoholic fatty liver disease].
Chen L; Jiang M; Xin Y; Wang J; Liu Y; Jiang X; Xuan S
Zhonghua Gan Zang Bing Za Zhi; 2016 Feb; 24(2):102-7. PubMed ID: 26983476
[TBL] [Abstract][Full Text] [Related]
28. Total Flavonoids from
Meng W; Zhao Z; Chen L; Lin S; Zhang Y; He J; Ouyang K; Wang W
Foods; 2022 Jul; 11(14):. PubMed ID: 35885412
[TBL] [Abstract][Full Text] [Related]
29. Establishment of a non-alcoholic fatty liver disease model by high fat diet in adult zebrafish.
Li X; Zhou L; Zheng Y; He T; Guo H; Li J; Zhang J
Animal Model Exp Med; 2023 Mar; ():. PubMed ID: 36942644
[TBL] [Abstract][Full Text] [Related]
30. Berberine ameliorates nonalcoholic fatty liver disease by decreasing the liver lipid content via reversing the abnormal expression of MTTP and LDLR.
Chen P; Li Y; Xiao L
Exp Ther Med; 2021 Oct; 22(4):1109. PubMed ID: 34504563
[TBL] [Abstract][Full Text] [Related]
31. Protection by the Total Flavonoids from
Dong L; Han X; Tao X; Xu L; Xu Y; Fang L; Yin L; Qi Y; Li H; Peng J
Foods; 2018 Jun; 7(6):. PubMed ID: 29890650
[TBL] [Abstract][Full Text] [Related]
32. Hepatoprotective Effect of Seed Coat ofEuryale ferox Extract in Non-alcoholic Fatty Liver Disease Induced by High-fat Diet in Mice by Increasing IRs-1 and Inhibiting CYP2E1.
Jian T; Yu C; Ding X; Chen J; Li J; Zuo Y; Ren B; Lv H; Li W
J Oleo Sci; 2019 Jun; 68(6):581-589. PubMed ID: 31092797
[TBL] [Abstract][Full Text] [Related]
33.
Zhang YH; Ma Q; Ding P; Li J; Chen LL; Ao KJ; Tian YY
Yonsei Med J; 2018 Nov; 59(9):1064-1071. PubMed ID: 30328321
[TBL] [Abstract][Full Text] [Related]
34. Aqueous Extract of Pepino (
Hsu JY; Lin HH; Hsu CC; Chen BC; Chen JH
Nutrients; 2018 Jul; 10(7):. PubMed ID: 30037014
[TBL] [Abstract][Full Text] [Related]
35. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
Wang M; Ma LJ; Yang Y; Xiao Z; Wan JB
Crit Rev Food Sci Nutr; 2019; 59(sup1):S116-S129. PubMed ID: 30580553
[TBL] [Abstract][Full Text] [Related]
36. Ginsenoside Rg1 Ameliorates Palmitic Acid-Induced Hepatic Steatosis and Inflammation in HepG2 Cells via the AMPK/NF-
Xiao Q; Zhang S; Yang C; Du R; Zhao J; Li J; Xu Y; Qin Y; Gao Y; Huang W
Int J Endocrinol; 2019; 2019():7514802. PubMed ID: 31467529
[TBL] [Abstract][Full Text] [Related]
37. Astragaloside IV Alleviates Atorvastatin-Induced Hepatotoxicity via AMPK/SIRT1 Pathway.
Qin L; Wang Y; Liang Y; Li Q; Xie X; Zhang H
Pharmacology; 2023; 108(1):74-82. PubMed ID: 36423574
[TBL] [Abstract][Full Text] [Related]
38. Protective Effect of Meretrix meretrix Oligopeptides on High-Fat-Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice.
Huang F; Wang J; Yu F; Tang Y; Ding G; Yang Z; Sun Y
Mar Drugs; 2018 Jan; 16(2):. PubMed ID: 29360762
[TBL] [Abstract][Full Text] [Related]
39. Elevated Apoptosis in the Liver of Dairy Cows with Ketosis.
Du X; Chen L; Huang D; Peng Z; Zhao C; Zhang Y; Zhu Y; Wang Z; Li X; Liu G
Cell Physiol Biochem; 2017; 43(2):568-578. PubMed ID: 28934742
[TBL] [Abstract][Full Text] [Related]
40. [Effect of Nrf2 and related factors on the progression of nonalcoholic steatohepatitis].
Cai YQ; Zhang LZ; Wang DJ; Chen FM; Chen ZY; Zhu KY; Li JS; Yan MX
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2014 Sep; 30(5):465-70. PubMed ID: 25571645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
